Form 4: Regeneron Pharmaceuticals Director George L. Sing Reports Gift of Shares
SEC Form 4 Filing
Director George L. Sing reports gifting 1,200 shares of Regeneron Pharmaceuticals common stock.
Summary
- On September 4, 2024, George L. Sing, a director of Regeneron Pharmaceuticals, reported a transaction involving the gifting of 1,200 shares of common stock.
- The shares were disposed of as a gift (Transaction Code 'G') at a price of $0.0.
- Following the transaction, Mr. Sing directly owns 26,272 shares of Regeneron common stock.
- He also indirectly owns 750 shares by spouse, 400 shares by spouse/custodian son, and 1,000 shares by trust for son.
Sentiment
Score: 5
Explanation: The document is a neutral report of a transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.
Stakeholder Impact
- The transaction itself is unlikely to have a significant impact on stakeholders.
- The disclosure provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 09/04/2024 | Date of transaction (gift of shares) |
| 09/05/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.